Mistletoe and Garlic Extracts as Polyurethane Carriers - A Possible Remedy for Choroidal Melanoma

Melania F Munteanu1, Aurel Ardelean1, Florin Borcan2

  • 1Faculty of General Medicine, Pharmacy and Dental Medicine, "Vasile Goldis" University, Arad, Arad. Romania.

Current Drug Delivery
|January 28, 2017
PubMed
Abstract

Insights

Polymer microstructures containing garlic or mistletoe extracts were developed for potential cancer treatments. Garlic extract showed promise for drug delivery, though antiproliferative effects were delayed due to slow polymer degradation.

Area of Science:

  • Polymer Science
  • Nanotechnology
  • Pharmacology

Background:

  • Malignant choroidal melanoma is a rare but serious intraocular cancer.
  • Garlic and mistletoe consumption are linked to reduced cancer risk in literature.

Purpose of the Study:

  • To create and characterize polymer structures encapsulating mistletoe or garlic extract.
  • To evaluate the potential of these structures as drug carriers for cancer therapy.

Main Methods:

  • Polyaddition and spontaneous emulsification for structure synthesis.
  • Characterization included pH, size, Zeta potential, DSC, encapsulation efficiency, membrane penetration, and cytotoxicity.
  • In vitro testing on A375 melanoma cells.

Main Results:

  • Microstructures ranged from 1.05–2.60 µm with Zeta potentials of -7 to +36 mV.
  • High encapsulation efficacy (88–92%) and 30% membrane penetration over 4 days.
  • Garlic extract showed cytotoxicity against A375 cells after 48–72 hours; however, polymer structures exhibited slow degradation, delaying antiproliferative activity.

Conclusions:

  • Sterile eye drop solutions containing garlic or mistletoe extracts in polymer microstructures were successfully produced.
  • Garlic-based formulations show potential as drug carriers with delayed antiproliferative effects for pharmaceutical applications.

Related Concept Videos